z-logo
open-access-imgOpen Access
The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients
Author(s) -
Arturo CérbuloVázquez,
Maritza García-Espinosa,
Jesús Carlos BrionesGarduño,
Lourdes ArriagaPizano,
Eduardo FeratOsorio,
Berenice Zavala-Barrios,
Graciela Libier CabreraRivera,
Patricia Miranda-Cruz,
María Teresa García de la Rosa,
Jessica L. PrietoChávez,
Vanessa Rivero-Arredondo,
Ruth L. Madera-Sandoval,
Alonso CruzCruz,
Enrique SalazarRíos,
María E. Salazar-Rios,
David Serrano-Molina,
R. C. De Lira-Barraza,
Abel Humberto VillanuevaCompean,
Alejandra EsquivelPineda,
Rubén RamírezMontes de,
Felipe CaldiñoSoto,
Luz Angélica Ramírez-García,
Guillermo Flores,
O. MorenoAlvarez,
Guadalupe GuerreroAvendaño,
Constantino LópezMacías
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0264566
Subject(s) - immunology , chemokine , medicine , immune system , immunophenotyping , peripheral blood mononuclear cell , serology , cytokine , covid-19 , monocyte , biology , flow cytometry , antibody , disease , infectious disease (medical specialty) , biochemistry , in vitro

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom